Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer
NCT00471276
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
83
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Neoplasms
Interventions
DRUG:
sunitinib
Sponsor
Pfizer